Potentiating the antitumour response of CD8+ T cells by modulating cholesterol metabolism-Reference-Cited by-同舟云学术

Potentiating the antitumour response of CD8+ T cells by modulating cholesterol metabolism

Published:2016-03-16 Issue:7596 Volume:531 Page:651-655
ISSN:0028-0836
Container-title:Nature
language:en
Short-container-title:Nature

Author:

Yang Wei,Bai Yibing,Xiong Ying,Zhang Jin,Chen Shuokai,Zheng Xiaojun,Meng Xiangbo,Li Lunyi,Wang Jing,Xu Chenguang,Yan Chengsong,Wang Lijuan,Chang Catharine C. Y.,Chang Ta-Yuan,Zhang Ti,Zhou Penghui,Song Bao-Liang,Liu Wanli,Sun Shao-cong,Liu Xiaolong,Li Bo-liang,Xu Chenqi

Publisher

Springer Science and Business Media LLC

Subject

Multidisciplinary

Link

http://www.nature.com/articles/nature17412.pdf

Reference38 articles.

1. Fridman, W. H., Pages, F., Sautes-Fridman, C. & Galon, J. The immune contexture in human tumours: impact on clinical outcome. Nature Rev. Cancer 12, 298–306 (2012)

2. Tumeh, P. C. et al. PD-1 blockade induces responses by inhibiting adaptive immune resistance. Nature 515, 568–571 (2014)

3. Mellman, I., Coukos, G. & Dranoff, G. Cancer immunotherapy comes of age. Nature 480, 480–489 (2011)

4. Joyce, J. A. & Fearon, D. T. T cell exclusion, immune privilege, and the tumor microenvironment. Science 348, 74–80 (2015)

5. Chang, T. Y., Chang, C. C., Ohgami, N. & Yamauchi, Y. Cholesterol sensing, trafficking, and esterification. Annu. Rev. Cell Dev. Biol. 22, 129–157 (2006)

Cited by 691 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Causal effects and metabolites mediators between immune cell and risk of colorectal cancer: a Mendelian randomization study;Frontiers in Immunology;2024-09-12

2. Metabolic reprogramming and immune evasion: the interplay in the tumor microenvironment;Biomarker Research;2024-09-03

3. Reprogramming the immunosuppressive tumor microenvironment through nanomedicine: an immunometabolism perspective;eBioMedicine;2024-09

4. Cobalt(III) prodrug-based nanomedicine for inducing immunogenic cell death and enhancing chemo-immunotherapy;Journal of Controlled Release;2024-09

5. PD-1 signaling limits expression of phospholipid phosphatase 1 and promotes intratumoral CD8+ T cell ferroptosis;Immunity;2024-09